MAP1LC3A and myalgic encephalomeyelitis/chronic fatigue syndrome: Each of the nine participating ME/CFS patients showed a reduction in their LC3-II levels after one session of WBH at a maximum core body temperature of 39 °C (Figure 1A; descriptive, without statistical tests).